Frontiers in Cellular Neuroscience, 2020 · DOI: 10.3389/fncel.2020.00201 · Published: June 30, 2020
Myelomeningocele (MMC) is a congenital defect where the spinal cord doesn't fully close during development, leading to the cord's exposure and progressive injury. This exposure to the intrauterine environment causes further damage, exacerbating neurological deficits beyond the initial malformation. Current research focuses on prenatal surgical repair and tissue engineering to protect the spinal cord and improve neurological outcomes, but a better understanding of the injury mechanisms is needed.
Further research into the mechanisms of spinal cord injury in MMC can lead to the development of targeted prenatal therapies to minimize neurological deficits.
Continued optimization of minimally invasive fetoscopic surgery and closure techniques can reduce maternal and fetal risks associated with open repair.
Identifying biomarkers that can detect the presence and progression of fetal spinal cord injury in MMC could aid in the timing of prenatal intervention.